Table 2.
Dose-escalation and DLT experience
Dose level | EKB-569 Dose (mg/d) | Capecitabine dose (mg/m2/twice daily) | No. of patients | No. of cycles | No. of patients with DLT |
---|---|---|---|---|---|
1 | 25 | 750 | 6 | 131 | 1 with grade 3 diarrhea |
2 | 50 | 750 | 7* | 42 | 1 with grade 3 diarrhea, hypotension, and dehydration |
3 | 50 | 1,000 | 20 | 86 | 1 with grade 3 diarrhea |
4 | 75 | 1,000 | 4 | 6 | 1 with grade 3 diarrhea |
1 with grade 2 diarrhea and rash | |||||
Total | 37 |
One patient was removed from the study on cycle 1, day 4 to receive palliative radiation and was not considered evaluable for dose escalation.